Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
Sokolenko AP, Sokolova TN, Ni VI, Preobrazhenskaya EV, Iyevleva AG, Aleksakhina SN, Romanko AA, Bessonov AA, Gorodnova TV, Anisimova EI, Savonevich EL, Bizin IV, Stepanov IA, Krivorotko PV, Berlev IV, Belyaev AM, Togo AV, Imyanitov EN.
Sokolenko AP, et al. Among authors: belyaev am.
Breast Cancer Res Treat. 2020 Nov;184(1):229-235. doi: 10.1007/s10549-020-05827-8. Epub 2020 Aug 9.
Breast Cancer Res Treat. 2020.
PMID: 32776218